Park National Corp’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.4M Buy
149,203
+1,478
+1% +$103K 0.34% 72
2025
Q1
$10.9M Sell
147,725
-6,407
-4% -$471K 0.4% 67
2024
Q4
$10.1M Buy
154,132
+911
+0.6% +$59.7K 0.37% 64
2024
Q3
$11.9M Sell
153,221
-8,161
-5% -$636K 0.42% 64
2024
Q2
$12.6M Buy
161,382
+19,499
+14% +$1.52M 0.47% 58
2024
Q1
$9.61M Sell
141,883
-4,263
-3% -$289K 0.37% 65
2023
Q4
$9.84M Buy
146,146
+7,196
+5% +$485K 0.4% 68
2023
Q3
$9.41M Sell
138,950
-1,801
-1% -$122K 0.43% 66
2023
Q2
$10.1M Sell
140,751
-8,168
-5% -$585K 0.44% 65
2023
Q1
$10.3M Sell
148,919
-1,886
-1% -$131K 0.46% 65
2022
Q4
$10.2M Buy
150,805
+70,057
+87% +$4.75M 0.46% 63
2022
Q3
$4.43M Sell
80,748
-1,068
-1% -$58.6K 0.22% 86
2022
Q2
$5.41M Sell
81,816
-14,154
-15% -$935K 0.26% 82
2022
Q1
$6.37M Sell
95,970
-13,674
-12% -$907K 0.26% 80
2021
Q4
$6.39M Sell
109,644
-25,588
-19% -$1.49M 0.25% 81
2021
Q3
$8.12M Sell
135,232
-31,151
-19% -$1.87M 0.34% 75
2021
Q2
$9.97M Sell
166,383
-143,512
-46% -$8.6M 0.42% 70
2021
Q1
$15.4M Buy
309,895
+611
+0.2% +$30.4K 0.68% 46
2020
Q4
$15.5M Buy
309,284
+6,345
+2% +$317K 0.72% 44
2020
Q3
$16.6M Sell
302,939
-2,176
-0.7% -$119K 0.87% 34
2020
Q2
$16.1M Sell
305,115
-12,674
-4% -$670K 0.9% 33
2020
Q1
$14.2M Buy
317,789
+3,014
+1% +$135K 0.9% 38
2019
Q4
$15.7M Buy
314,775
+10,078
+3% +$502K 0.8% 41
2019
Q3
$13.6M Buy
304,697
+26,426
+9% +$1.18M 0.74% 41
2019
Q2
$11.5M Buy
278,271
+40,391
+17% +$1.67M 0.62% 44
2019
Q1
$9.62M Buy
237,880
+62,399
+36% +$2.52M 0.54% 49
2018
Q4
$6.67M Buy
175,481
+100,111
+133% +$3.8M 0.41% 54
2018
Q3
$2.98M Buy
+75,370
New +$2.98M 0.16% 90